|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| CURRENT ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Government grant receivable | ||||||||||||||||||||
| Contract Assets | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| TOTAL CURRENT ASSETS | ||||||||||||||||||||
| Land | ||||||||||||||||||||
| Other property and equipment, net | ||||||||||||||||||||
| Costs subject to amortization | ||||||||||||||||||||
| Costs not being amortized | ||||||||||||||||||||
| Office equipment | ||||||||||||||||||||
| Accumulated depletion, depreciation, amortization, and impairment | ||||||||||||||||||||
| Total | ||||||||||||||||||||
| PROPERTY AND EQUIPMENT, NET | ||||||||||||||||||||
| Equity investment – Hupecol Meta LLC | ||||||||||||||||||||
| Refundable acquisition deposit | ||||||||||||||||||||
| Capitalized patents | ||||||||||||||||||||
| Deposits on license agreements | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Technology licenses | ||||||||||||||||||||
| Capitalized patents, net | ||||||||||||||||||||
| Operating lease right of use asset | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| TOTAL OTHER ASSETS | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| CURRENT LIABILITIES | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Notes payable – related party, net | ||||||||||||||||||||
| Convertible note payable | ||||||||||||||||||||
| HUSA Convertible Note Payable | ||||||||||||||||||||
| Abundia Global Impact Group LLC | ||||||||||||||||||||
| Total convertible note payable | ||||||||||||||||||||
| Note payable – related party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total note payable – related party | ||||||||||||||||||||
| Convertible note payable measured at fair value- related party | ||||||||||||||||||||
| Current portion of lease liability | ||||||||||||||||||||
| Warrant liabilities | ||||||||||||||||||||
| Other payables | ||||||||||||||||||||
| TOTAL CURRENT LIABILITIES | ||||||||||||||||||||
| LONG-TERM LIABILITIES | ||||||||||||||||||||
| AGIG convertible note payable | ||||||||||||||||||||
| Convertible note payable | ||||||||||||||||||||
| Operating lease liability, net of current portion | ||||||||||||||||||||
| Asset retirement obligation | ||||||||||||||||||||
| TOTAL LONG-TERM LIABILITIES | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| Common stock, par value $0.001 per share; 300,000,000 shares authorized: 44,150,321 and 36,918,281 shares issued and outstanding as of June 30, 2026, and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Equity in RPD prior to acquisition | ||||||||||||||||||||
| Non-controlling interest | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| TOTAL SHAREHOLDERS’ EQUITY/(DEFICIT) | ||||||||||||||||||||
| Other comprehensive income (loss) | ||||||||||||||||||||
| Noncontrolling interest in consolidated subsidiary | ||||||||||||||||||||
| TOTAL SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
Loading...